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Abstract: Three new azaphilone compounds, isochromophilones X–XII (1–3), together with two known ones sclerotioramine (4) 
and isochromophilone VI (5) were isolated from the cultures of an endophytic fungus Diaporthe sp. The structures were elucidated 
by extensive HRESIMS and NMR spectroscopic analyses. All compounds were tested for their cytotoxicities against five human 
cancer cell lines by MTT method, among which compound 1 showed moderate inhibitory effects on these cell lines. This was the 
first report of azaphilones isolated from Diaporthe sp. 
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Introduction 
The azaphilones are a structurally diverse family of natural 
products containing a highly oxygenated, bicyclic core and a 
chiral quaternary center. The name of azaphilone arose as a 
result of their affinity for ammonia: the pigments react with 
amines, such as proteins, amino acids and nucleic acids, to 
form red and purple vinylogous -pyridones due to the  
exchange of pyrane oxygen for nitrogen1–3. Azaphilone  
compounds had a wide range of bioactivities including  
cytotoxic, antifungal, antimicrobial, antioxidant and anti-
inflammatory activities,4–8 and could be generally produced by 
Penicillium, Chaetomium and Monascus.3 In the course of our 
search for novel and/or bioactive metabolites from microbes 
lived in special niche,4,9,10 five azaphilones including three new 
isochromophilones X–XII (1–3) and two known compounds 
sclerotioramine (4)11 and isochromophilone VI (5)12 were  
isolated from the solid-substrate fermentation cultures of an 
endophytic fungus Diaporthe sp. The structures were  
identified on the basis of extensive spectroscopic methods. 
The cytotoxic activities of compounds (1–5) against human 
gastric cancer SGC-7901, colorectal carcinoma SW1116, 
breast adenocarcinoma MCF-7, lung adenocarcinoma 
epithelial A549 and melanoma A375 cells were evalutated by 
MTT method. Compound 1 exhibited moderate cytotoxic  
activities with its IC50 values ranging from 14.90–35.75 μM. 
 
Results and Discussion 
Compound 1 was obtained as red needles, the molecular 
formula was assigned as C29H32ClNO4 evidenced by its 
HRESIMS spectrum at m/z 494.2080 [M + H]+ (calcd. for 
C29H3335ClNO4, 494.2098), indicating 14 degrees of 
unsaturation. Compound 1 displayed similar 1H NMR 
spectrum to that of known compound isochromophilone VI (5) 
except for a monosubstituted benzene ring signals [δ 7.26 (m, 
1H), 7.32 (m, 2H), 7.10 (d, 7.0, 2H)] in 1, which suggested 
that the 2'-OH in isochromophilone VI (5) could be replaced 
by a benzene ring in compound 1. To confirm the proposed 
structure, extensive NMR spectra have been investigated 
(Figure 2). 1H-1H COSY correlations of H-10/H-11, and of 
Me-18/H-13/H-14/H-15(Me-17)/Me-16, together with the 
HMBC correlations from H-10 to C-12, H-11 to C-18, H-13 to 
C-11, C-15, C-17, C-18 indicated the presence of a 3,5-
dimethyl-1,3-heptadiene residue. On the basis of the coupling 
constants of H-10, H-11, and the NOE correlation of H-11 
with H-13, the configurations of these two double bonds were 
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Figure 1.  Compounds 1–5 from Diaporthe sp. 
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C-3', H-4' to C-2', H-7' to C-3' confirmed the linkage of C-2' 
and the benzene ring. Moreover, the HMBC correlations of H-
1 to C-1', C-2, C-4, C-5, C-8, C-9, of H-3 to C-5 and C-10, of 
Me-19 to C-6, C-8 indicated the presence of isoquinoline-
6,8(2H,7H)-dione moiety, a typical group in azaphilone 
skeleton and the way the residues linked at. Thus, the planar 
structure of 1 was established. 
Compound 2, isolated as red needles, was determined to 
have the molecular formula C27H30ClNO3 (13 degrees of 
unsaturation) based on an HRESIMS peak at m/z 452.1998 [M 
+ H]+ (calcd. for C27H3135ClNO3, 452.1992), 42 amu (C2H2O) 
less than compound 1. Its 1H NMR spectrum revealed nearly 
all identical structural features to those found in compound 1, 
except the absence of an acetyl signal in the 1H NMR spectrum 
(Table 1) and thus the structure of compound 2 could be 
readily determined as shown in Figure 1 which was supported 
by 2D NMR spectra. 
Compound 3 was established the molecular formula as 
C31H33ClN2O4 by HRESIMS analysis (m/z 533.2203, calcd. for 
C31H3435ClN2O4, 533.2207) with 16 degrees of unsaturation. 
The 1H NMR spectroscopic data of compound 3 were well 
comparable to those of 1. Considering the molecular formula, 
an indole ring might substitute 2'-OH of isochromophilone VI 
in the compound 3. The HMBC (Figure 2) correlations from 
H-10' to C-4' and C-9', from H-5' to C-7' and C-9', from  
H-8' to C-4' and C-6' confirmed the presence of indole ring. 
The 7R-configurations of isochromophilones X–XII (1–3) 
were determined by circular-dichroism (CD) spectroscopy. 
The observed positive Cotton effect at the wavelength (370–
390 nm) was well comparable to that of 7R-5-chloro-7,8-
dihydro-3-(3-hydroxypropyl)-7-methyl-6,8-dioxo-6H-2-benzo-
pyran-7-yl ester.13,14 Furthermore, the 14S-configurations of  
1–3 were determined by comparing their NMR data of the side 
chain moieties with those of  similar azaphilone compounds, 
isochromophilone Ia, IIa and rotiorinol A.15,16 
Biosynthetically, azaphilone was derived from the 
polyketide pathway,3,17 whose oxygen atom could be further 
substituted by primary amines or ammonia into N-containing 
compounds rapidly.1 For example, sclerotiorin could be 
converted to sclerotioramine (4) with ammonia.2 Thus, 
compounds 1 and 3 were deduced as consequences of 
sclerotiorin reacting with phenylethanamine and tryptamine, 
the decarboxylated product of phenylalanine and tryptophan, 
respectively (Scheme 1). The further deacetylation of 
compound 1 gave compound 2. Also, we can deduce that 
compounds 1–3 possessed the same configurations as that of 
sclerotiorin (Figure 1) by their biosynthetic view. 
Table 1. 1H (500MHz) and 13C NMR (125MHz) data for 1–3 (in CDCl3) 
 
No. 
1 2 3 
δH (mult., J)                         δC δH (mult., J)                            δC δH (mult., J)                            δC 
1 7.53 (s) 140.8, CH 7.49 (s) 140.0, CH 7.49 (s) 141.0, CH 
2  147.8, C  148.3, C  148.3, C 
3 6.96 (s) 111.5, CH 6.96 (s) 111.0, CH 6.94 (s) 111.4, CH 
4  144.3, C  145.7, C  144.6, C 
5  103.1, C  100.0, C 102.1, C 
6  184.3, C  187.6, C  207.3, C 
7  84.8, C  83.4, C  84.8, C 
8  193.7, C  196.3, C  193.8, C 
9  114.6, C  115.5, C  114.6, C 
10 5.98 (d, 15.5) 114.6, CH 6.02 (d, 15.5) 114.4, CH 5.85 (d, 15.0) 114.8, CH 
11 6.90 (d, 15.5) 144.9, CH 6.94 (d, 15.5) 145.3, CH 6.84 (d, 15.0) 144.9, CH 
12  131.5, C  131.5, C  131.7, C 
13 5.68 (d, 9.5) 148.0, CH 5.71 (d, 10.0) 148.4, CH 5.63 (d, 9.5) 147.7, CH 
14 2.47 (m) 35.0, CH 2.49 (m) 35.1, CH 2.43 (m) 35.0, CH 
15 1.44 (m); 1.35 (m) 30.0, CH2 1.44 (m); 1.34 (m) 30.0, CH2 1.42 (m); 1.33 (m) 30.1, CH2 
16 0.89 (t, 7.5) 11.9, CH3 0.89 (t, 7.5) 11.9, CH3 0.87 (t, 7.5) 12.0, CH3
17 1.03 (d, 6.5) 20.2, CH3 1.03 (d, 6.6) 20.2, CH3 1.00 (d, 6.5) 20.2, CH3 
18 1.81 (d, 1.0) 12.6, CH3 1.83 (s) 12.6, CH3 1.56 (s) 12.1, CH3 
19 1.52 (s) 23.2, CH3 1.51 (s) 29.5, CH3 1.48 (s) 23.2, CH3 
7-OAc 2.16 (s) 20.3, CH3   2.17 (s) 20.3, CH3 
  170.0, C    170.1, C 
1' 4.13 (m); 3.98 (m) 55.4, CH2 4.17 (m); 4.03 (m) 55.6, CH2 4.11 (m) 54.5, CH2 
2' 3.02 (m) 36.6, CH2 3.05 (m) 36.4, CH2 3.20 (m) 26.5, CH2 
3'  135.8, C  135.6, C  109.6, C 
4' 7.10 (d, 7.0) 128.7, CH 7.08 (d, 7.0) 128.7, CH  126.7, C 
5' 7.32 (m) 129.2, CH 7.32 (m) 129.3, CH 7.48 (d, 8.0) 117.7, CH
6' 7.26 (m) 127.7, CH 7.26 (m) 127.8, CH 7.14 (t, 8.0) 120.1, CH 
7' 7.32 (m) 129.2, CH 7.32 (m) 129.3, CH 7.22 (t, 8.0) 122.7, CH 
8' 7.10 (d, 7.0) 128.7, CH 7.08 (d, 7.0) 128.7, CH 7.37 (d, 8.0) 111.8, CH 
9'      136.5, C 
10'     6.94 (s) 123.2, CH 
  
Figure 2.  Key 1H-1H COSY (bold), HMBC (arrow) correla-
tions of 1 and 3 
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All compounds were evaluated for their cytotoxicities 
against MCF-7, SGC-7901, SW1116, A549 and A375 cell 
lines by MTT method. Only, isochromophilone X (1) showed 
moderate cytotoxic activities with its IC50 values of 14.90, 
16.84, 24.15, 26.93 and 35.75 μM against MCF-7, SGC-7901, 
SW1116, A549 and A375 cell lines (Table 2), respectively, 
while the other compounds exhibited no activities with IC50 
values greater than 50 μM. 
 
Experimental Section 
General Experimental Procedures. HRESIMS spectra 
were recorded on an Agilent 6210 TOF LC/MS. CD spectra 
were obtained on a JASCO J-810 spectrometer. IR spectra 
were obtained on a Nexus 870 FT-IR spectrometer. NMR 
spectra were recorded on Bruker AV-500, AV-300 or 
DRX500 NMR spectrometer. Optical rotations were recorded 
on a Rudolph Autopol III automatic polarimeter. UV spectra 
were recorded on a Hitachi U-3000 spectrophotometer. Silica 
gel (200–300 mesh; Qingdao Marine Chemical Factory, Qing-
dao, China) and Sephadex LH-20 gel (Pharmacia Biotech, 
Sweden) were used for column chromatography (CC). HPLC 
was performed with a Hitachi L-7110 pump, and UV detector 
L-7400 equipped with an Apollo C18 column (5 μm, 250 mm 
× 4.6 mm; Alltech Associates, Inc. Chicago, IL, USA). 
 
The Fungal Material and Cultivation Conditions. The 
strain IFB-3lp-10 was isolated from the healthy leaves of  
Rhizophora stylosa collected in August 2010 from the man-
grove forest of Hainan Province of China. The strain was  
identified as Diaporthe sp. by comparing the morphological 
character and 18S rDNA sequence with that of a standard  
record. A voucher specimen has been deposited in the Institute 
of Functional Biomolecules, State Key Laboratory of  
Pharmaceutical Biotechnology, Nanjing University. After 
growing on PDA medium at 28 °C for 5 d, the fungus  
Diaporthe sp. IFB-3lp-10 was inoculated into Erlenmeyer 
flasks (1000 mL) containing 400 mL of ME liquid medium. 
After incubation for 4 d at 28 °C on a rotary shaker at 150 rpm, 
20 mL of culture liquid was transferred as the seed into 250 
mL flasks, each preloaded with the evenly mingled medium 
(7.5 g of grain, 7.5 g of bran, 0.5 g of yeast extract, 0.1 g of 
sodium tartrate, 0.01 g of FeSO4·7H2O, 0.1 g of sodium  
glutamate and 30 ml of H2O). The fungus then grew for 30 d at 
28 °C with the relative humidity in the range 60–70%. 
 
Extraction and Isolation. The air-dried samples (30 kg) 
were extracted with 95% EtOH and the organic solvent was 
evaporated to dryness under a vacuum to afford a crude extract 
(1.2 kg) which gave six fractions (Fr.1, 21g; Fr.2, 75 g; Fr.3, 
56 g; Fr.4, 25 g; Fr.5, 36 g; Fr.6, 158 g) upon column  
chromatography (10 × 120 cm) on silica gel (6000 g, 200–300 
mesh) eluted with a gradient of CH2Cl2/MeOH (v/v 100:0, 
100:1, 100:2, 100:4, 100:8, 100:20, 0:100, each 20L) based on 
TLC monitoring. Purification of the second subfraction 
(CH2Cl2/MeOH 100:1) by using column chromatography  
(petroleum ether/EtOAc 1:1) and Sephadex LH-20 (100% 
MeOH) followed by HLPC (90% MeOH) gave 1 (15.0 mg) 
and 2 (2.5 mg). Purification of the third subfraction 
(CH2Cl2/MeOH 100:2) in the same way mentioned above gave 
3 (3.6 mg). The fourth fraction was subjected to reversed 
phase ODS column (4 cm × 40 cm) with a gradient of 
MeOH/H2O (v/v 20:80, 30:70, 40:60, 50:50, 60:40, 70:30, 
80:20, 90:10, 100:0, each 3 L) to give nine subfractions, re-
spectively. Purification of the fifth subfraction (MeOH/H2O 
60:40) by using column chromatography (petroleum 
ether/EtOAc 1:2) and Sephadex LH-20 (100 % MeOH) gave 4 
(2.8 g) and 5 (64 mg). 
 
Isochromophilones X (1): red needles. [α]20D   = ＋1116.4 (c 
= 0.028, MeOH). UV/Vis (MeOH): λmax/nm (log ε) = 201 (4.5), 
227 (4.4), 373 (4.5). CD (c 2.8 × 10−4 g ml−1, MeOH) max/nm 
(): 229.5 (+0.4), 246 (+6.2), 304 (−8.9), 381.5 (+7.9), 429 
(+1.2). IR (KBr): vmax = 3490.4, 2960.7, 2924.7, 1701.8, 
1594.6, 1501.6, 1262.5, 1220.3, 1144.3, 1081.7, 1032.0, 801.9 
cm−1. HRESIMS: m/z 494.2080 ([M + H]+, calcd. for 
C29H3335ClNO4, 494.2098). For 1H and 13C NMR spectroscopic 
data, see Table 1. 
 
Isochromophilones XI (2): red needles. [α]20D   = ＋596.0 (c 
= 0.08, MeOH). UV/ Vis (MeOH): λmax/nm (log ε) = 206 (4.5), 
228 (4.5), 350 (4.5). CD (c 8.0 × 10−4 g ml−1, MeOH) max/nm 
(): 209 (+5.6), 236 (+0.6), 249 (+1.4), 311 (−4.3), 375 
(+3.6), 414.5 (+0.5). IR (KBr): vmax = 3419.2, 2962.5, 1588.8, 
1494.7, 1261.5, 1096.2, 1033.4, 801.5 cm−1. HRESIMS: m/z 
452.1998 ([M + H]+, calcd. for C27H3135ClNO3, 452.1992). For 
1H and 13C NMR spectroscopic data, see Table 1. 
 
Isochromophilones XII (3): red needles. [α]20D   = ＋936.0 (c 
= 0.025, MeOH). UV/ Vis (MeOH): λmax/nm (log ε) = 201 
(4.6), 221 (4.7), 375 (4.3). CD (c 2.5 × 10−4 g ml−1, MeOH) 
λmax/nm (): 229.5 (−1.6), 246.5 (+2.4), 304.5 (−4.5), 379 
 
Scheme 1.  Proposed biogenetic pathway for isochromophilones
X–XII (1–3) 
Table 2. In vitro cytotoxicity of compound 1 
IC50 (μM) MCF-7 SGC-7901 SW1116 A549 A375 
1 14.90 ± 2.41 16.84 ± 1.06 24.15 ± 1.77 26.93 ± 1.17 35.75 ± 2.11 
Doxorubicin•HCla 0.55 ± 0.03 2.03 ± 0.05 5.09 ± 1.13 3.37 ± 1.66 1.75 ± 0.24 
aused as a positive control 
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(+3.5), 419.5 (+0.3). IR (KBr): vmax = 3440.3, 3237.5, 2958.9, 
1736.0, 1574.3, 1486.1, 1219.3, 1145.0, 758.9 cm−1. 
HRESIMS: m/z 533.2203 ([M + H]+, calcd. for 
C31H3435ClN2O4, 533.2207). For 1H and 13C NMR spectroscopic
data, see Table 1. 
 
Cytotoxicity Assay. The cytotoxic effects of 1–5 on the  
viability of the SGC-7901, SW1116, MCF-7, A549 and A375 
cell lines were assayed with the MTT [3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide] colorimetric method. 
The data represent the mean of three experiments performed in 
triplicate and are expressed as means ± SD. 
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